Abstract
Breast cancer is the second most diagnosed malignancy in American women with a lifetime occurrence of 1 in 8 women in the United States. There has been a dearth of research focusing on regional differences in breast cancer mortality with respect to race in the US. It is crucial to identify regions that are lagging to uplift the outreach of breast cancer care to certain races. Data for this study were obtained from the 2016–2018 Nationwide Inpatient Sample. In-hospital mortality, race and hospital regions for the patients with the primary diagnosis of Malignant Neoplasms of Breast were studied. Baseline characteristics of participants were summarized using descriptive statistics. The patient population was stratified as per race, hospital region, gender, therapy received and family history. Logistic regression was performed to derive the odds ratio while adjusting for different variables. 99, 543 patients with metastatic breast cancer were identified. African Americans (AAs) were found to have the highest reported deaths at 5.54%, followed by Asians and Pacific Islanders at 4.80% and Caucasians 4.09% (p < 0.0001). The odds of dying were significantly higher in the AA population when compared to Caucasian population (OR 1.391 (1.286–1.504)), and the odds were consistently higher across all regions of the US. In terms of regional disparities with respect to race, AA’s had highest mortality in the south whereas all other races had the highest mortality in the west. It was seen that races identifying as “others” had significantly higher odds of dying in the Northeast. It is crucial to identify racial differences in the various regions across the US in order to implement appropriate outreach strategies to tackle these disparities.
Similar content being viewed by others
References
Giaquinto AN, Sung H, Miller KD, et al. Breast cancer statistics, 2022. CA Cancer J Clin. 2022;72(6):524–41. https://doi.org/10.3322/CAAC.21754.
Siegel Mph RL, Miller KD, Sandeep N, et al. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17–48. https://doi.org/10.3322/CAAC.21763.
Iqbal J, Ginsburg O, Rochon PA, Sun P, Narod SA. Differences in breast cancer stage at diagnosis and cancer-specific survival by race and ethnicity in the United States. JAMA. 2015;313(2):165–73. https://doi.org/10.1001/JAMA.2014.17322.
Rauscher GH, Silva A, Pauls H, Frasor J, Bonini MG, Hoskins K. Racial disparity in survival from estrogen and progesterone receptor positive breast cancer: implications for reducing breast cancer mortality disparities. Breast Cancer Res Treat. 2017;163(2):321. https://doi.org/10.1007/S10549-017-4166-Z.
Kim G, Pastoriza JM, Qin J, et al. Racial disparity in distant recurrence-free survival in patients with localized breast cancer: a pooled analysis of National Surgical Adjuvant Breast and Bowel Project trials. Cancer. 2022;128(14):2728–35. https://doi.org/10.1002/CNCR.34241.
Chang CS, Kitamura E, Johnson J, Bollag R, Hawthorn L. Genomic analysis of racial differences in triple negative breast cancer. Genomics. 2019;111(6):1529–42. https://doi.org/10.1016/J.YGENO.2018.10.010.
Babatunde OA, Eberth JM, Felder T, et al. Social determinants of racial disparities in breast cancer mortality among black and white women. J Racial Ethn Health Disparities. 2021;8(1):147. https://doi.org/10.1007/S40615-020-00766-Y.
Yu XQ. Socioeconomic disparities in breast cancer survival: relation to stage at diagnosis, treatment and race. BMC Cancer. 2009;9(1):364. https://doi.org/10.1186/1471-2407-9-364/COMMENTS.
Coughlin SS. Social determinants of breast cancer risk, stage, and survival. Breast Cancer Res Treat. 2019;177(3):537–48. https://doi.org/10.1007/S10549-019-05340-7.
Hardy D, Du DY. Socioeconomic and racial disparities in cancer stage at diagnosis, tumor size, and clinical outcomes in a large cohort of women with breast cancer, 2007–2016. J Racial Ethn Health Disparities. 2021;8(4):990–1001. https://doi.org/10.1007/S40615-020-00855-Y.
Duma N, Aguilera JV, Paludo J, et al. Representation of minorities and women in oncology clinical trials: review of the past 14 years. J Oncol Pract. 2018;14(1):e1–10. https://doi.org/10.1200/JOP.2017.025288.
Khandwala P, Desai D, Das DG, Desai A (2020) Racial disparities in cancer clinical trials. 38(Suppl 29):97–97.https://doi.org/10.1200/JCO.2020.38.29_SUPPL.97
Aldrighetti CM, Niemierko A, van Allen E, Willers H, Kamran SC. Racial and ethnic disparities among participants in precision oncology clinical studies. JAMA Netw Open. 2021;4(11):e2133205–e2133205. https://doi.org/10.1001/JAMANETWORKOPEN.2021.33205.
Grette KV, White AL, Awad EK, et al. Not immune to inequity: minority under-representation in immunotherapy trials for breast and gynecologic cancers. Int J Gynecol Cancer. 2021. https://doi.org/10.1136/IJGC-2021-002557.
San Miguel Y, Gomez SL, Murphy JD, et al. Age-related differences in breast cancer mortality according to race/ethnicity, insurance, and socioeconomic status. BMC Cancer. 2020;20(1):1–9. https://doi.org/10.1186/S12885-020-6696-8/TABLES/3.
Lorona NC, Malone KE, Li CI. Racial/ethnic disparities in risk of breast cancer mortality by molecular subtype and stage at diagnosis. Breast Cancer Res Treat. 2021;190(3):549–58. https://doi.org/10.1007/S10549-021-06311-7.
Ooi SL, Martinez ME, Li CI. Disparities in breast cancer characteristics and outcomes by race/ethnicity. Breast Cancer Res Treat. 2011;127(3):729–38. https://doi.org/10.1007/S10549-010-1191-6.
Jatoi I, Sung H, Jemal A. The emergence of the racial disparity in U.S. breast-cancer mortality. N Engl J Med. 2022;386(25):2349–52. https://doi.org/10.1056/NEJMP2200244/SUPPL_FILE/NEJMP2200244_DISCLOSURES.PDF.
Whitman S, Orsi J, Hurlbert M. The racial disparity in breast cancer mortality in the 25 largest cities in the United States. Cancer Epidemiol. 2012;36(2):e147–51. https://doi.org/10.1016/J.CANEP.2011.10.012.
Singh GK, Jemal A. Socioeconomic and racial/ethnic disparities in cancer mortality, incidence, and survival in the United States, 1950–2014: over six decades of changing patterns and widening inequalities. J Environ Public Health. 2017. https://doi.org/10.1155/2017/2819372.
Bradley CJ, Given CW, Roberts C. Race, socioeconomic status, and breast cancer treatment and survival. J Natl Cancer Inst. 2002;94(7):490–6. https://doi.org/10.1093/JNCI/94.7.490.
Sighoko D, Hunt BR, Irizarry B, Watson K, Ansell D, Murphy AM. Disparity in breast cancer mortality by age and geography in 10 racially diverse US cities. Cancer Epidemiol. 2018;53:178–83. https://doi.org/10.1016/J.CANEP.2018.02.003.
Eley JW, Hill HA, Greenberg RS, et al. Racial differences in survival from breast cancer: results of the National Cancer Institute Black/White cancer survival study. JAMA. 1994;272(12):947–54. https://doi.org/10.1001/JAMA.1994.03520120057031.
Ko NY, Hong S, Winn RA, Calip GS. Association of insurance status and racial disparities with the detection of early-stage breast cancer. JAMA Oncol. 2020;6(3):385–92. https://doi.org/10.1001/JAMAONCOL.2019.5672.
Spada NG, Geramita EM, Zamanian M, van Londen GJ, Sun Z, Sabik LM. Changes in disparities in stage of breast cancer diagnosis in pennsylvania after the Affordable Care Act. J Womens Health. 2021;30(3):324–31. https://doi.org/10.1089/JWH.2020.8478.
Carey LA, Perou CM, Livasy CA, et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA. 2006;295(21):2492–502. https://doi.org/10.1001/JAMA.295.21.2492.
Shoemaker ML, White MC, Wu M, Weir HK, Romieu I. Differences in breast cancer incidence among young women aged 20–49 years by stage and tumor characteristics, age, race, and ethnicity, 2004–2013. Breast Cancer Res Treat. 2018;169(3):595–606. https://doi.org/10.1007/S10549-018-4699-9.
Chlebowski RT, Chen Z, Anderson GL, et al. Ethnicity and breast cancer: factors influencing differences in incidence and outcome. J Natl Cancer Inst. 2005;97(6):439–47. https://doi.org/10.1093/JNCI/DJI064.
Nahleh Z, Otoukesh S, Mirshahidi HR, et al. Disparities in breast cancer: a multi-institutional comparative analysis focusing on American Hispanics. Cancer Med. 2018;7(6):2710–7. https://doi.org/10.1002/CAM4.1509.
Williams F, Thompson E. Disparities in breast cancer stage at diagnosis: importance of race, poverty, and age. J Health Dispar Res Pract. 2017;10(3):34.
Bickell NA, Wang JJ, Oluwole S, et al. Missed opportunities: racial disparities in adjuvant breast cancer treatment. J Clin Oncol. 2006;24(9):1357–62. https://doi.org/10.1200/JCO.2005.04.5799.
Reeder-Hayes KE, Meyer AM, Dusetzina S, Liu H, Wheeler SB. Racial disparities in initiation of adjuvant endocrine therapy of early breast cancer. Breast Cancer Res Treat. 2014;145(3):743–51. https://doi.org/10.1007/S10549-014-2957-Z.
McCarthy EP, Burns RB, Coughlin SS, et al. Mammography use helps to explain differences in breast cancer stage at diagnosis between older black and white women. Ann Intern Med. 1998;128(9):729–36. https://doi.org/10.7326/0003-4819-128-9-199805010-00005.
Teysir J, Gegechkori N, Wisnivesky JP, Lin JJ. Racial disparities in surveillance mammography among older breast cancer survivors. Breast Cancer Res Treat. 2019;176(2):461–7. https://doi.org/10.1007/S10549-019-05250-8.
Miller BC, Bowers JM, Payne JB, Moyer A. Barriers to mammography screening among racial and ethnic minority women. Soc Sci Med. 2019;239:112494. https://doi.org/10.1016/J.SOCSCIMED.2019.112494.
Gerend MA, Pai M. Social determinants of Black-White disparities in breast cancer mortality: a review. Cancer Epidemiol Biomark Prev. 2008;17(11):2913–23. https://doi.org/10.1158/1055-9965.EPI-07-0633.
Choi JJ, Fikre T, Fischman A, Buck AK, Ko NY. The role of race and insurance status in access to genetic counseling and testing among high-risk breast cancer patients. Oncologist. 2022;27(10):832. https://doi.org/10.1093/ONCOLO/OYAC132.
Zahnd WE, Ranganathan R, Adams SA, Babatunde OA. Sociodemographic disparities in molecular testing for breast cancer. Cancer Causes Control. 2022;33(6):843–59. https://doi.org/10.1007/S10552-022-01575-W.
DeGuzman PB, Cohn WF, Camacho F, Edwards BL, Sturz VN, Schroen AT. Impact of urban neighborhood disadvantage on late stage breast cancer diagnosis in Virginia. J Urban Health. 2017;94(2):199. https://doi.org/10.1007/S11524-017-0142-5.
Tammemagi CM, Nerenz D, Neslund-Dudas C, Feldkamp C, Nathanson D. Comorbidity and survival disparities among Black and White patients with breast cancer. JAMA. 2005;294(14):1765–72. https://doi.org/10.1001/JAMA.294.14.1765.
Murthy VH, Krumholz HM, Gross CP. Participation in cancer clinical trials: race-, sex-, and age-based disparities. JAMA. 2004;291(22):2720–6. https://doi.org/10.1001/JAMA.291.22.2720.
Moubadder L, Collin LJ, Nash R, et al. Drivers of racial, regional, and socioeconomic disparities in late-stage breast cancer mortality. Cancer. 2022;128(18):3370–82. https://doi.org/10.1002/CNCR.34391.
Weber JJ, Kachare SD, Vohra NA, Fitzgerald TF, Wong JH. Regional disparities in breast cancer outcomes and the process of care. AM Surg. 2014;80(7):669–74. https://doi.org/10.1177/000313481408000721.
Parise CA, Caggiano V. Regional variation in disparities in breast cancer specific mortality due to race/ethnicity, socioeconomic status, and urbanization. J Racial Ethn Health Disparities. 2017;4(4):706–17. https://doi.org/10.1007/S40615-016-0274-4.
Kyalwazi AN, Loccoh EC, Brewer LC, et al. Disparities in cardiovascular mortality between Black and White adults in the United States, 1999 to 2019. Circulation. 2022;146(3):211–28. https://doi.org/10.1161/CIRCULATIONAHA.122.060199.
Singh GK, Azuine RE, Siahpush M, Williams SD. Widening geographical disparities in cardiovascular disease mortality in the United States, 1969–2011. Int J MCH AIDS. 2015;3(2):134. https://doi.org/10.21106/ijma.46.
Cross SH, Mehra MR, Bhatt DL, et al. Rural-urban differences in cardiovascular mortality in the US, 1999–2017. JAMA. 2020;323(18):1852–4. https://doi.org/10.1001/JAMA.2020.2047.
Grann V, Troxel AB, Zojwalla N, Hershman D, Glied SA, Jacobson JS. Regional and racial disparities in breast cancer-specific mortality. Soc Sci Med. 2006;62(2):337–47. https://doi.org/10.1016/J.SOCSCIMED.2005.06.038.
Acknowledgements
This data has previously been presented as an Abstract at ASCO Annual Meeting 2022.
Funding
The authors declare that no funds, grants, or other support were received during the preparation of this manuscript.
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by DD. The first draft of the manuscript was written by AK and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors have no relevant financial or non-financial interests to disclose.
Informed consent
Informed consent was not obtained as the data were obtained from NIS and was anonymized.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Khosla, A., Desai, D., Singhal, S. et al. Racial and regional disparities in deaths in breast cancer. Med Oncol 40, 210 (2023). https://doi.org/10.1007/s12032-023-02083-w
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s12032-023-02083-w